financetom
Business
financetom
/
Business
/
Bullish Stock Soars In IPO Debut: Details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bullish Stock Soars In IPO Debut: Details
Aug 13, 2025 12:06 PM

Peter Thiel-backed Bullish opened for trading at $90.45 per share on Monday, well-above its IPO price of $37 per share. 

BLSH stock is open for trading. Watch the real-time price action here. 

BLSH Explodes Onto The Market

Bullish shares surged higher and trading was halted with the stock up more than 200% shortly after its market debut. At the time of the volatility halt, the company had a market cap of more than $16 billion. 

Read Next: Retail Crowd’s Top Stocks With Earnings This Week: Archer, Rigetti, Oklo And More

The blockbuster opening highlighted oversubscribed interest in BLSH stock which included indications from large institutions like BlackRock and ARK Invest to participate in the deal.

Bullish Company Info: 

Bullish operates a cryptocurrency exchange geared to institutional clients and also owns CoinDesk, a prominent crypto media and data brand. The company, led by former NYSE Group president Tom Farley and backed by Thiel, a billionaire investor, was founded in 2021. 

The firm's Bullish crypto exchange offers spot and derivatives trading, reporting cumulative platform volumes above $1 trillion since launch as of this year's filings. 

Investor attention has focused on Bullish's scale, brand assets, and institutional orientation as potential differentiators, alongside near-term financial momentum as crypto gains traction with mainstream investors. 

With the BLSH listing, Bullish becomes one of the year's most-watched crypto market debuts, adding to a streak of recent high-profile IPOs. 

BLSH Stock Price: Bullish stock was trading at $82.95 at the time of publication Wednesday, according to data from Benzinga Pro. 

Read Next: 

Quantum Stock Tracker: D-Wave, IonQ Q2 Earnings Roll In

Image: Shutterstock 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Ripple Acquires Prime Broker Hidden Road For $1.25 Billion
Ripple Acquires Prime Broker Hidden Road For $1.25 Billion
Apr 8, 2025
Ripple, the blockchain firm behind XRP (CRYPTO: XRP), has signed an agreement to acquire prime brokerage firm Hidden Road in a deal valued at $1.25 billion. The acquisition represents Ripple's most significant move yet to expand its offerings for institutional clients, according to CEO Brad Garlinghouse. What Happened: Speaking to Fortune, Garlinghouse emphasized the importance of building a stronger foundation...
Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps
Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps
Apr 8, 2025
Pacira BioSciences, Inc ( PCRX ). on Monday settled its litigations with Fresenius Kabi USA, Jiangsu Hengrui Pharmaceuticals Co., Ltd., and eVenus Pharmaceuticals Laboratories, Inc. related to patents for Exparel (bupivacaine liposome injectable suspension). Exparel is Pacira BioSciences' ( PCRX ) non-opioid analgesic pain management and is indicated for postsurgical analgesia. As part of the settlement, the parties will file...
WD-40 Raises Full-Year Earnings Outlook, Expects 'Minimal' Tariffs Impact
WD-40 Raises Full-Year Earnings Outlook, Expects 'Minimal' Tariffs Impact
Apr 8, 2025
10:44 AM EDT, 04/08/2025 (MT Newswires) -- WD-40 ( WDFC ) lifted its full-year earnings outlook as the maker of lubricants and cleaning products said it expects a minimal impact from US President Donald Trump's recently announced tariffs. The company now expects earnings of $5.25 to $5.55 per share for fiscal 2025, up from its previous guidance of $5.20 to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved